The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Hymenolepis


High impact information on Hymenolepis


Biological context of Hymenolepis


Anatomical context of Hymenolepis


Associations of Hymenolepis with chemical compounds

  • The effect of worm age, weight and number in the infection on the absorption of glucose by Hymenolepis diminuta [17].
  • Mebendazole and the development of Hymenolepis nana in mice [18].
  • Niclosamide as a treatment for Hymenolepis diminuta and Dipylidium caninum infection in man [19].
  • With the enzyme from L1210 cells and the tapeworm Hymenolepis diminuta, AZTMP was a weak inhibitor competitive with respect to dUMP (Ki = 6.3 mM and 0.5 mM); hence cytotoxicity of AZT, in cells in which accumulation of AZTMP is not high, is not due to inhibition of cellular thymidylate synthase [20].
  • In vivo treatment with a therapeutically effective dose of ABZ caused a severe disturbance in the energy balance of Hymenolepis diminuta; this was evident from a distinct drop in ATP levels, and from a decline in the ATP/ADP ratios, adenylate energy charge (AEC) and available adenylate energy (AAE) values.(ABSTRACT TRUNCATED AT 250 WORDS)[21]

Gene context of Hymenolepis


Analytical, diagnostic and therapeutic context of Hymenolepis


  1. Parasite-specific antibody profile in human fascioliasis: application for immunodiagnosis of infection. Maher, K., El Ridi, R., Elhoda, A.N., El-Ghannam, M., Shaheen, H., Shaker, Z., Hassanein, H.I. Am. J. Trop. Med. Hyg. (1999) [Pubmed]
  2. Hymenolepis diminuta infection in a child living in the urban area of Rome, Italy. Marangi, M., Zechini, B., Fileti, A., Quaranta, G., Aceti, A. J. Clin. Microbiol. (2003) [Pubmed]
  3. Serotoninlike immunoreactivity in the cestode Hymenolepis diminuta. Webb, R.A., Mizukawa, K. J. Comp. Neurol. (1985) [Pubmed]
  4. Comparison of formalin-ethyl ether sedimentation, formalin-ethyl acetate sedimentation, and zinc sulfate flotation techniques for detection of intestinal parasites. Truant, A.L., Elliott, S.H., Kelly, M.T., Smith, J.H. J. Clin. Microbiol. (1981) [Pubmed]
  5. Immunosuppressive and antiparasitic effects of cyclosporin A on Hymenolepis nana infection in mice. Matsuzawa, K., Nakamura, F., Abe, M., Okamoto, K. Int. J. Parasitol. (1998) [Pubmed]
  6. Importance of interferon-gamma in protective immunity against Hymenolepis nana cysticercoids derived from challenge infection with eggs in BALB/c mice. Asano, K., Muramatsu, K. Int. J. Parasitol. (1997) [Pubmed]
  7. Rhodoquinone requirement of the Hymenolepis diminuta mitochondrial electron transport system. Fioravanti, C.F., Kim, Y. Mol. Biochem. Parasitol. (1988) [Pubmed]
  8. The role of glucose in the lipid metabolism of the rat tapeworm Hymenolepis diminuta. Webb, R.A., Mettrick, D.F. Int. J. Parasitol. (1975) [Pubmed]
  9. Kinetics of mast cells, eosinophils and phospholipase B activity in the spontaneous-cure response of two strains of mice (rapid and slow responder) to the cestode Hymenolepis nana. Bortoletti, G., Gabriele, F., Palmas, C. Parasitol. Res. (1989) [Pubmed]
  10. An acute dose of monosodium L-glutamate causes decreased fecundity and enhanced loss of the cestode Hymenolepis diminuta from rats. Webb, R.A. Parasitol. Res. (1995) [Pubmed]
  11. The effect of L-glutamate and related agents on adenylate cyclase in the cestode Hymenolepis diminuta. Eklove, H., Webb, R.A. Can. J. Physiol. Pharmacol. (1991) [Pubmed]
  12. Alterations in brush border membrane proteins and membrane-bound enzymes of the tapeworm, Hymenolepis diminuta, during development in the definitive host. Pappas, P.W., Narcisi, E.M., Rentko, V. Mol. Biochem. Parasitol. (1983) [Pubmed]
  13. Effects of cyclophosphamide and dexamethasone on mast cell populations in Hymenolepis microstoma-infected mice. Novak, M., Buchannan, L.G., Howlader, H. Parasitology (1990) [Pubmed]
  14. Inhibitory action of deoxyspergualin on effector/memory T cell generation during Hymenolepis nana infection in mice. Asano, K., Muramatsu, K., Ikeda, K., Okamoto, K. Immunol. Lett. (1996) [Pubmed]
  15. Partial characterization of the protein and carbohydrate constituents of the egg shell of Hymenolepis diminuta (Cestoda). Pappas, P.W., Durka, G.M. Int. J. Parasitol. (1994) [Pubmed]
  16. Blocking factors and the isolation of glutathione transferases from Hymenolepis diminuta (Cestoda: Cyclophyllidea). Brophy, P.M., Barrett, J. Parasitology (1990) [Pubmed]
  17. The effect of worm age, weight and number in the infection on the absorption of glucose by Hymenolepis diminuta. Henderson, D. Parasitology (1977) [Pubmed]
  18. Mebendazole and the development of Hymenolepis nana in mice. Novak, M., Evans, W.S. Int. J. Parasitol. (1981) [Pubmed]
  19. Niclosamide as a treatment for Hymenolepis diminuta and Dipylidium caninum infection in man. Jones, W.E. Am. J. Trop. Med. Hyg. (1979) [Pubmed]
  20. Interaction of the 5'-phosphates of the anti-HIV agents, 3'-azido-3'-deoxythymidine and 3'-azido-2',3'-dideoxyuridine, with thymidylate synthase. Dzik, J.M., Bretner, M., Kulikowski, T., Ciesla, J., Ciesla, J.M., Rode, W., Shugar, D. Biochem. Biophys. Res. Commun. (1988) [Pubmed]
  21. A possible biochemical mode of action for benzimidazole anthelmintics. McCracken, R.O., Stillwell, W.H. Int. J. Parasitol. (1991) [Pubmed]
  22. STAT-6 is an absolute requirement for murine rejection of Hymenolepis diminuta. McKay, D.M., Khan, W.I. J. Parasitol. (2003) [Pubmed]
  23. In vitro oncospheral agglutination given by immune sera from mice infected, and rabbits injected, with eggs of Hymenolepis nana. Ito, A. Parasitology (1975) [Pubmed]
  24. Immunodiagnosis of human cysticercosis (Taenia solium): a field comparison of an antibody-enzyme-linked immunosorbent assay (ELISA), an antigen-ELISA, and an enzyme-linked immunoelectrotransfer blot (EITB) assay in Peru. The Cysticercosis Working Group in Peru (CWG). Diaz, J.F., Verastegui, M., Gilman, R.H., Tsang, V.C., Pilcher, J.B., Gallo, C., Garcia, H.H., Torres, P., Montenegro, T., Miranda, E. Am. J. Trop. Med. Hyg. (1992) [Pubmed]
  25. Intramitochondrial localization of fumarate reductase, NADPH----NAD transhydrogenase, 'malic' enzyme and fumarase in adult Hymenolepis diminuta. McKelvey, J.R., Fioravanti, C.F. Mol. Biochem. Parasitol. (1985) [Pubmed]
  26. Immune response to the cestode Hymenolepis nana: cytokine production during infection with eggs or cysts. Conchedda, M., Bortoletti, G., Gabriele, F., Wakelin, D., Palmas, C. Int. J. Parasitol. (1997) [Pubmed]
  27. Glycosaminoglycans of tegumental fractions of Hymenolepis diminuta. Robertson, N.P., Cain, G.D. Mol. Biochem. Parasitol. (1984) [Pubmed]
  28. Quantitative determination of inositol in Hymenolepis diminuta (Cestoda). Ip, Y.K., Fisher, F.M. J. Parasitol. (1982) [Pubmed]
  29. Hymenolepis diminuta metacestodes (Cysticeroids) are unable to utilize exogenous trehalose. Pappas, P.W., Morrison, S.E. J. Parasitol. (1995) [Pubmed]
  30. Detection of serum antibodies in human Hymenolepis infection by enzyme immunoassay. Gómez-Priego, A., Godínez-Hana, A.L., Gutiérrez-Quiroz, M. Trans. R. Soc. Trop. Med. Hyg. (1991) [Pubmed]
WikiGenes - Universities